Aquaro Histology Completes $9.8M Series A Funding

Aquaro Histology, Inc. (formerly known as Aquaro Biosystems, LLC), an Ann Arbor, Mich-based developer of products for the histology laboratory, completed a $9.8m Series A funding.

The round was led by Telegraph Hill Partners. Concurrent with the financing, Tom Raffin, M.D., Deval Lashkari, Ph.D., and Rob Hart, J.D., all members of Telegraph Hill Partners, joined Aquaro Histology’s existing Board of Directors.

The company intends to use the funds to launch its first product, the Aquaro ASM™ (Automated Section Mounting), expand its commercial efforts, and support and grow its research and operational organization.

Led by CEO Alberto Elli, and Jack Ball, Executive Chairman, Aquaro Histology develops user-centric products for the histology laboratory. The company’s first product, the Aquaro ASM, automates microtomy, not just the microtome, by transferring sections from the blade to slides.
The Aquaro ASM facilitates hands-free microtomy in histology laboratories by transferring paraffin-embedded sections from the blade to slides. The system interfaces with existing motorized microtomes, allowing the ASM to be integrated into current histology laboratory workflows. The Aquaro ASM relaxes sections at a user-controlled temperature and time. Sections can be placed on the top, middle, or bottom of the slide, and can be mounted serially or from different levels of the block.



Join the discussion